Linda Grais

Linda S.
Grais was the founder of Structural Genomix, Inc., founded in 1997, where the title held was Executive Vice President from 1997 to 2004.
Dr. Grais was the founder of SGX Pharmaceuticals, Inc., founded in 1998, where the title held was Executive Vice President from 1998 to 2003.
Current jobs include Independent Director at Corvus Pharmaceuticals, Inc. since 2019; Director at The J.
David Gladstone Institutes; Director at CollectiveHealth, Inc. since 2023; Director at Research Bridge Partners; Director at PartnersGlobal; Independent Non-Executive Director at ICON plc since 2021; and Director at Iolyx Therapeutics, Inc. Former jobs include President, Chief Executive Officer & Director at OCERA Therapeutics LLC from 2012 to 2017; Independent Director at PRA Health Sciences, Inc. from 2015 to 2021; Independent Director at Zosano Pharma Corp.; Independent Director at Deerfield Healthcare Technology Acquisitions Corp.; Independent Director at ARCA biopharma, Inc. from 2007 to 2011; Attorney at Wilson Sonsini Goodrich & Rosati PC from 1993 to 1997; Assistant Clinical Professor at The University of California, San Francisco; and Managing Member & Partner at InterWest Venture Management Co. from 2005 to 2011.
Education includes an undergraduate degree from Yale University conferred in 1979, a doctorate from Yale School of Medicine conferred in 1984, and a graduate degree from Stanford Law School conferred in 1993.